Incidence, Characteristics and Implications of Thromboembolic Events in Patients with Muscle Invasive Urothelial Carcinoma of the Bladder Undergoing Neoadjuvant Chemotherapy

Article ID	Journal	Published Year	Pages	File Type
5687227	The Journal of Urology	2016	7 Pages	PDF

Abstract

Thromboembolic events are common in patients with muscle invasive bladder cancer who undergo neoadjuvant chemotherapy before and after radical cystectomy. Our results suggest that a prospective trial of thromboembolic event prophylaxis during neoadjuvant chemotherapy is warranted.

Keywords

NAC methotrexate, vinblastine, doxorubicin and cisplatin MIBC MVAC TEE Pulmonary embolism Thromboembolism DVT Deep vein thrombosis computerized tomography thromboembolic event Muscle invasive bladder cancer Urinary bladder neoplasms Cystectomy Radical cystectomy Neoadjuvant chemotherapy neoadjuvant therapy

Related Topics

Health Sciences Medicine and Dentistry Nephrology

Preview

Incidence, Characteristics and Implications of Thromboembolic Events in Patients with Muscle Invasive Urothelial Carcinoma of the Bladder Undergoing Neoadjuvant Chemotherapy

Authors

Wilhelmina C.M. Duivenvoorden, Siamak Daneshmand, Daniel Canter, Yair Lotan, Peter C. Black, Hamidreza Abdi, Bas W.G. van Rhijn, Elisabeth E. Fransen van de Putte, Piotr Zareba, Ilmari Koskinen, Wassim Kassouf, Samer L. Traboulsi, Janet E. Kukreja,